A Single Centre, Open-Label Study to Evaluate the Immunogenicity and Safety of Enzira Vaccine in Healthy Adults aged >= 18 to < 60 years and in Healthy Older Adults aged > 60 years for the 2007/2008 Northern Hemisphere Influenza Season.
Phase of Trial: Phase IV
Latest Information Update: 08 Oct 2013
At a glance
- Drugs Influenza virus vaccine (Afluria) (Primary)
- Indications Influenza virus infections
- Focus Therapeutic Use
- Sponsors CSL
- 15 Mar 2012 Actual end date (22 Jun 2007) added as reported by European Clinical Trials Database.
- 15 Mar 2012 Actual initiation date (17 May 2007) added as reported by European Clinical Trials Database.
- 15 Mar 2012 Status changed from recruiting to completed as reported by European Clinical Trials Database.